We are honored to announce that the following group of distinguished and renowned scientists have accepted the invitation to serve on the Scientific Advisory Board of Aithyra, the Research Institute for Biomedical Artificial Intelligence of the Austrian Academy of Sciences.
- Jim Collins (MIT) – synthetic biology
- Stefan Fröhling (NCT Heidelberg) – clinical oncology
- Pim Haselager (Radboud) – AI ethics
- Edith Heard (Crick) – cell biology
- Tommi Jaakkola (MIT) – ML for molecular design
- Debora Marks (Harvard) – protein design
- Michele Parrinello (ETHZ/IIT) – molecular dynamics
- Dana Pe’er (Sloan Kettering) – single cell, spatial biology
- Ton Schumacher (NKI) – (immuno-)oncology
- Kevan Shokat (UCSF) – chemistry, chemical biology
- Eric Xing (MBZUAI/CMU) – biological foundation models & general AI
The Aithyra Directors, Faculty, and our still growing scientific community are looking forward to regular interactions, feedback on Aithyra's research endeavors, as well as input on organizational and entrepreneurial developments of the institute. For the Aithyra stakeholders, the Austrian Academy of Sciences and the not-for-profit Boehringer Ingelheim Foundation, the SAB report will be of great value. The presence, attention and strategic advice of the SAB will provide additional motivation to set and reach ambitious goals!
#AITHYRA #AithyraSAB